申请人:Noronha Glenn
公开号:US20070149508A1
公开(公告)日:2007-06-28
A compound is provided, having the general structure (A):
wherein A is an (un)substituted aryl or (un)substituted heteroaryl moiety, G is N, CH, or CR, R is an unsubstituted or substituted lower alkyl, Y is a hydrophobic linking moiety, and L is a substitutent as defined. The compound (A) can be used for treatment of various angiogenic and hematological-associated disorders, such as myeloproliferative disorder in patients who do not respond to kinase-inhibition therapy that comprises administering approved medications.
提供了一种化合物,其一般结构为(A):其中A是(未)取代芳基或(未)取代杂环芳基基团,G是N、CH或CR,R是未取代或取代的较低烷基,Y是疏水连接基团,L是定义的取代基。化合物(A)可用于治疗各种与血管生成和血液学有关的疾病,例如在不对包括给予批准药物的激酶抑制治疗做出反应的患者中的骨髓增生性疾病。